Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 3Neoplasm Metastasis 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Nonsquamous Non-small Cell Lung Cancer 1Non-Small Cell Lung Cancer Metastatic 1Neoplasms 1Melanoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

patritumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer × patritumab deruxtecan × Thoracic × Clear all
NCT06099639 2025-06-08

Medical Access Program for Patritumab Deruxtecan

Daiichi Sankyo

No longer available
Thoracic

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡